Department of Health Management Centre, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Department of General Practice, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Public Health Nutr. 2024 Jun 5;27(1):e158. doi: 10.1017/S1368980024001253.
This study aimed to analyse the spatial and temporal patterns of disease burden attributed to high BMI (DB-hBMI) from 1990 to 2019 in Belt and Road Initiative (BRI) countries, in light of increasing hBMI prevalence worldwide.
The study was a secondary analysis of Global Burden of Disease 2019 (GBD 2019) that analysed (using Joinpoint regression analysis) numbers and the age-standardised rate of mortality and disability-adjusted life years (DALY) of hBMI-induced diseases and their trends from 1990 to 2019 and in the final decade.
GBD 2019 study data for BRI countries were categorised by country, age, gender and disease.
GBD 2019 data were used to analyse DB-hBMI in BRI countries.
In 2019, China, India and Russia reported the highest mortality and DALY among BRI countries. From 1990 to 2019, the age-standardised DALY increased in Southeast Asia and South Asia, whereas many European countries saw declines. Notably, Bangladesh, Nepal and Vietnam showed the steepest increases, with average annual percentage change (AAPC) values of 4·42 %, 4·19 % and 4·28 %, respectively (all < 0·05). In contrast, Israel, Slovenia and Poland experienced significant reductions, with AAPC values of -1·70 %, -1·63 % and -1·58 %, respectively (all < 0·05). The most rapid increases among males were seen in Vietnam, Nepal and Bangladesh, while Jordan, Poland and Slovenia recorded the fastest declines among females. Across most BRI countries, the burden of diabetes and kidney diseases related to hBMI showed a significant uptrend.
DB-hBMI varies significantly by region, age, gender and disease type across BRI countries. It can pose a substantial threat to public health.
本研究旨在分析 2019 年“一带一路”倡议（BRI）国家因高 BMI（DB-hBMI）导致的疾病负担的时空模式，鉴于全球范围内 BMI 升高的流行率不断上升。
本研究为 2019 年全球疾病负担（GBD 2019）的二次分析，使用 Joinpoint 回归分析分析了 1990 年至 2019 年以及最后十年因 hBMI 导致的疾病数量和死亡率以及残疾调整生命年（DALY）的年龄标准化率及其趋势。
按国家、年龄、性别和疾病对 GBD 2019 研究中 BRI 国家的 GBD 2019 数据进行分类。
使用 GBD 2019 数据分析 BRI 国家的 DB-hBMI。
2019 年，中国、印度和俄罗斯报告了 BRI 国家中最高的死亡率和 DALY。1990 年至 2019 年期间，东南亚和南亚的年龄标准化 DALY 增加，而许多欧洲国家则有所下降。值得注意的是，孟加拉国、尼泊尔和越南的增幅最大，年均百分比变化（AAPC）值分别为 4.42%、4.19%和 4.28%（均<0.05）。相比之下，以色列、斯洛文尼亚和波兰经历了显著的下降，AAPC 值分别为-1.70%、-1.63%和-1.58%（均<0.05）。男性中增长最快的是越南、尼泊尔和孟加拉国，而女性中下降最快的是约旦、波兰和斯洛文尼亚。在大多数 BRI 国家中，与 hBMI 相关的糖尿病和肾脏疾病的负担呈显著上升趋势。
DB-hBMI 在 BRI 国家因地区、年龄、性别和疾病类型而异。它可能对公共健康构成重大威胁。
